Clinical Trial Update: Effect of Vaginal Estrogen on Alterations in the Urine Microbiome of Menopausal Women With Overactive Bladder [Phase 4]

View source ↗

Summary

A completed Phase 4 study evaluated how vaginal estrogen influences alterations in the urine microbiome of menopausal women with overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause
• Overactive Bladder

Drugs mentioned

• Estradiol vaginal estrogen (estradiol)

Snippet

Sponsor: Mahidol University | Conditions: Overactive Bladder (OAB), Menopause | Phase 4 | Status: COMPLETED